Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release

Cardiovascular diseases such as myocardial infarction or limb ischemia are characterized by regression of blood vessels. Local delivery of growth factors (GFs) involved in angiogenesis such as fibroblast blast growth factor-2 (FGF-2) has been shown to trigger collateral neovasculature and might lead...

Full description

Saved in:
Bibliographic Details
Main Authors: Aurelien Forget, V. Prasad Shastri
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomimetics
Subjects:
Online Access:https://www.mdpi.com/2313-7673/10/1/12
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588962679488512
author Aurelien Forget
V. Prasad Shastri
author_facet Aurelien Forget
V. Prasad Shastri
author_sort Aurelien Forget
collection DOAJ
description Cardiovascular diseases such as myocardial infarction or limb ischemia are characterized by regression of blood vessels. Local delivery of growth factors (GFs) involved in angiogenesis such as fibroblast blast growth factor-2 (FGF-2) has been shown to trigger collateral neovasculature and might lead to a therapeutic strategy. In vivo, heparin, a sulfated polysaccharide present in abundance in the extracellular matrix (ECM), has been shown to function as a local reservoir for FGF-2 by binding FGF-2 and other morphogens and it plays a role in the evolution of GF gradients. To access injectable biomaterials that can mimic such natural electrostatic interactions between soluble signals and macromolecules and mechanically tunable environments, the backbone of agarose, a thermogelling marine–algae-derived polysaccharide, was modified with sulfate, phosphate, and carboxylic moieties and the interaction and release of FGF-2 from these functionalized hydrogels was assessed by ELISA in vitro and CAM assay in ovo. Our findings show that FGF-2 remains active after release, and FGF-2 release profiles can be influenced by sulfated and phosphorylated agarose, and in turn, promote varied blood vessel formation kinetics. These modified agaroses offer a simple approach to mimicking electrostatic interactions experienced by GFs in the extracellular environment and provide a platform to probe the role of these interactions in the modulation of growth factor activity and may find utility as an injectable gel for promoting angiogenesis and as bioinks in 3D bioprinting.
format Article
id doaj-art-38e16a28dcc64afda5c10870534464b1
institution Kabale University
issn 2313-7673
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomimetics
spelling doaj-art-38e16a28dcc64afda5c10870534464b12025-01-24T13:24:35ZengMDPI AGBiomimetics2313-76732024-12-011011210.3390/biomimetics10010012Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 ReleaseAurelien Forget0V. Prasad Shastri1Institute for Macromolecular Chemistry, Stefan-Meier-Strasse 31, 79104 Freiburg, GermanyInstitute for Macromolecular Chemistry, Stefan-Meier-Strasse 31, 79104 Freiburg, GermanyCardiovascular diseases such as myocardial infarction or limb ischemia are characterized by regression of blood vessels. Local delivery of growth factors (GFs) involved in angiogenesis such as fibroblast blast growth factor-2 (FGF-2) has been shown to trigger collateral neovasculature and might lead to a therapeutic strategy. In vivo, heparin, a sulfated polysaccharide present in abundance in the extracellular matrix (ECM), has been shown to function as a local reservoir for FGF-2 by binding FGF-2 and other morphogens and it plays a role in the evolution of GF gradients. To access injectable biomaterials that can mimic such natural electrostatic interactions between soluble signals and macromolecules and mechanically tunable environments, the backbone of agarose, a thermogelling marine–algae-derived polysaccharide, was modified with sulfate, phosphate, and carboxylic moieties and the interaction and release of FGF-2 from these functionalized hydrogels was assessed by ELISA in vitro and CAM assay in ovo. Our findings show that FGF-2 remains active after release, and FGF-2 release profiles can be influenced by sulfated and phosphorylated agarose, and in turn, promote varied blood vessel formation kinetics. These modified agaroses offer a simple approach to mimicking electrostatic interactions experienced by GFs in the extracellular environment and provide a platform to probe the role of these interactions in the modulation of growth factor activity and may find utility as an injectable gel for promoting angiogenesis and as bioinks in 3D bioprinting.https://www.mdpi.com/2313-7673/10/1/12biomimeticangiogenesisgrowth factorscontrolled releaseregenerative medicine
spellingShingle Aurelien Forget
V. Prasad Shastri
Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release
Biomimetics
biomimetic
angiogenesis
growth factors
controlled release
regenerative medicine
title Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release
title_full Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release
title_fullStr Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release
title_full_unstemmed Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release
title_short Sulfated and Phosphorylated Agarose as Biomaterials for a Biomimetic Paradigm for FGF-2 Release
title_sort sulfated and phosphorylated agarose as biomaterials for a biomimetic paradigm for fgf 2 release
topic biomimetic
angiogenesis
growth factors
controlled release
regenerative medicine
url https://www.mdpi.com/2313-7673/10/1/12
work_keys_str_mv AT aurelienforget sulfatedandphosphorylatedagaroseasbiomaterialsforabiomimeticparadigmforfgf2release
AT vprasadshastri sulfatedandphosphorylatedagaroseasbiomaterialsforabiomimeticparadigmforfgf2release